Search Result For
Result(s) found: 25
Oerlikon’s sales rise by 3%
Oerlikon Group’s EBITDA was sustained at a high level at CHF 93 million and a margin of 15.0 per cent. EBIT for Q1 2019 stood at CHF 44 million, or 7.1 per cent of sales.
Filatex reports 50% YoY growth for Q2FY19
Filatex India Limited, a leading manufacturer of synthetic man-made filament yarns, said its Q2FY19 net profit increased 50 per cent to Rs 20.25 crore as the company opened a new production line. Revenue rose 73 per cent to Rs 718 crore during the July-September quarter. The results are unaudited.
Oerlikon achieves strong growth in all segments
In 2017, Oerlikon delivered on its targets and recorded top-line growth as well as improved operating profitability across all segments.Dr Roland Fischer, CEO Oerlikon Group, said, The year 2017 marks a year of strong financial performance for the group and across all segments
Oerlikon Records Q1 Top-Line Results
Bolstered by the exceptional top-line performance and reinforced by disciplined cost management, the Group’s year-on-year EBITDA increased to CHF 123 million, yielding a high EBITDA margin of 15.1 per cent.
Clariant starts 2018 with good growth in sales
Clariant, a world leader in speciality chemicals, has announced first quarter 2018 sales of CHF 1.722 billion compared to CHF 1.602 billion in the first quarter of 2017.
Arvind Q3 revenue rises 16%
Arvind Ltd’s consolidated revenue for Q3 grew 16 per cent at Rs 2,706 crore over the corresponding quarter of the previous year.
LANXESS on course for record year
Following an excellent third quarter of 2017, specialty chemicals company LANXESS is still on course for the highest earnings in its history.
Double-digit profitability in Oerlikon's MMF segment
The Manmade Fibres Segment of Oerlikon captured a significant share of the business in the filament equipment market, where a high level of demand prevailed, particularly in China.
“We are pleased to announce another quarter of profitable growth”, said Dr Roland Fischer, CEO of Oerlikon Group. “Our positive performance confirms that our strategy addresses attractive markets, our initiatives and activities are delivering positive results, and we are able to take advantage of the growth momentum and opportunities in our end markets. Consequently, we are in a position to increase our full-year expectations for the second time this year.”